We are monitoring the impact of COVID-19 & Recession alarm on Latin America Renal Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Renal Disease Therapeutics Market Research Report – Segmented By Application, Treatment Devices & Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1221
Pages: 145

The Latin America Renal Disease Therapeutics Market size is estimated to grow at a steady CAGR between 2022 and 2027. The Latin American market is estimated to create impressive growth opportunities with increasing support from governments in the field of research and development in the health sector.

The growing prevalence of renal diseases, worsened by the geriatric population and increasing life expectancy, will continue to drive demand for renal replacement treatment (RRT), which is directly expected to accelerate the growth of the Latin America renal disease therapeutics market.

Renal diseases are very common in people with kidney stones, diabetes, prostate cancer, liver failure, etc. Various factors like unhealthy lifestyle habits, smoking, drug abuse, heavy alcohol consumption, and long-term side effects of medications increase the rate of renal disease. Stimulated by this and the increased population rate, the demand for renal diseases like a chronic renal failure (CRF), end-stage renal failure (ESRD), acute renal failure, renal stone, renal tumors, etc., is estimated to increase in the estimated years. In 2020, the population of Latin America and the Caribbean was 657,355,600, or 8.86% of the total world population. The prevalence of ESRD in RRT has increased from 109 patients per million in the early 2000s.

According to the Latin American Society of Nephrology and Hypertension / Latin American Society of Nephrology and Hypertension, the acceptance rate for RRT is 104 new patients per million population. In Latin America, hemodialysis is done as replacement therapy for ESRD and renal transplants. Approximately 30% of renal failure people are undergoing hemodialysis/peritoneal dialysis (PD) in Latin America. In particular, Mexico is the country with the highest PD use globally. Furthermore, it is estimated that around 26% of the world's PD population is found in Latin America.

Rising healthcare costs and poor healthcare infrastructure are limiting the growth of the Latin American renal disease therapeutics market. Reducing costs in the health sector is a significant challenge in this region due to poor economic status. And strict government policies regarding the approval of medical equipment and drugs are a long and tedious process challenging the frequency of product launches.

This research report on the Latin American renal disease therapeutics market has been segmented and sub-segmented into the following categories:

By Treatment:

  • Dialysis Equipment
  • Renal Denervation Devices
  • Wearable Artificial Kidney Device
  • Distal Embolic Protection Devices

By Application Mode:

  • Kidney Stone Disease
  • End-Stage Kidney Disease
  • Kidney Failure
  • Chronic Kidney Disease
  • Hypertension
  • Diabetes
  • Anemia

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, Brazil is estimated to experience steady growth in the Latin American renal disease therapeutics market during the studied period. The market growth is mainly due to the increasing prevalence of chronic disease, improving health infrastructure, and increasing health spending. In addition to this, various government authorities plan to carry out awareness-raising actions on renal health care. Therefore, the market will eventually benefit from a significant boost from such initiatives. According to the Centers for Disease Control and Prevention (CDC), approximately 8.1 million people suffer from severe kidney disease. This shows that the demand for prognostic CRF is estimated to increase over the forecast period.

Diabetes continued to be the leading cause of ESRD, with numbers showing the highest incidence reported in Puerto Rico (66.85%), Mexico (61.85%), and Colombia (42.99%), and the lowest in Cuba (26.27%) and Uruguay. (23.29%). The prevalence and incidence of RRT continue to increase. In Latin American countries, health coverage for RRT has varying rates compared to rates in developed countries with higher gross national income. This region is reported to have growth opportunities with strategies adopted by the major players, including collaborations, the development of technologically advanced drugs, and acquisitions to strengthen their position in the market.

KEY MARKET PLAYERS:

Companies playing an influential role in the Latin America Renal disease therapeutics market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, and Davita Healthcare Partners.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Kidney Stone Disease         

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure        

                                5.1.5 Chronic Kidney Disease     

                                5.1.6 Hypertension        

                                5.1.7 Diabetes  

                                5.1.8 Anaemia  

                                5.1.4 Y-o-Y Growth Analysis, By Application         

                                5.1.5 Market Attractiveness Analysis, By Application        

                                5.1.6 Market Share Analysis, By Application         

                5.2 Treatment devices                  

                                5.2.1 Introduction           

                                5.2.2 Dialysis Equipment              

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device   

                                5.2.5 distal embolic protection devices  

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices           

                                5.2.7 Market Attractiveness Analysis, By Treatment devices         

                                5.2.8 Market Share Analysis, By Treatment devices          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Treatment Devices

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Treatment devices

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Treatmentr Devices

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Amgen Inc.                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co., Inc.                     

                8.3 Bristol-Myers Squibb Company                          

                8.4 Hoffmann-La Roche Inc                         

                8.5 Shire Inc.                     

                8.6 Fresenius Medical Care                         

                8.7 Baxter International               

                8.8 Davita Healthcare Partners                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Renal Disease Therapeutics Market, By Application Mode, From 2022 - 2027 (USD Billion)
  2. Latin America Kidney Stone Disease Market, By Region, From 2022 - 2027 (USD Billion)
  3. Latin America End-Stage Kidney Disease Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Kidney Failure Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Chronic Kidney Disease Market, By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Hypertension Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Anemia Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Renal Disease Therapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  10. Latin America Dialysis Equipment Market, By Region, From 2022 - 2027 (USD Billion)
  11. Latin America Renal Denervation Devices Market, By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Wearable Artificial Kidney Device Market, By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Distal Embolic Protection Devices Market, By Region, From 2022 - 2027 (USD Billion)
  14. Brazil Renal Disease Therapeutics Market, By Application Mode, From 2022 - 2027 (USD Billion)
  15. Brazil Renal Disease Therapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  16. Argentina Renal Disease Therapeutics Market, By Application Mode, From 2022 - 2027 (USD Billion)
  17. Argentina Renal Disease Therapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  18. Mexico Renal Disease Therapeutics Market, By Application Mode, From 2022 - 2027 (USD Billion)
  19. Mexico Renal Disease Therapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  20. Rest of Latin America Renal Disease Therapeutics Market, By Application Mode, From 2022 - 2027 (USD Billion)
  21. Rest of Latin America Renal Disease Therapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample